Blueprint Medicines Corporation (BPMC)

NASDAQ: BPMC · IEX Real-Time Price · USD

110.36

+1.18 (1.08%)

At close: Jul 2, 2024, 4:00 PM

109.00

-1.36 (-1.23%)

After-hours: Jul 2, 2024, 4:56 PM EDT

Blueprint Medicines Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2013
Revenue	249.38	204.04	180.08	793.74	66.51	Upgrade
Revenue Growth (YoY)	22.22%	13.30%	-77.31%	1093.37%	49.39%	Upgrade
Cost of Revenue	12.8	26.76	25.74	0.43	0	Upgrade
Gross Profit	236.58	177.28	154.35	793.31	66.51	Upgrade
Selling, General & Admin	295.14	237.37	195.29	157.74	96.39	Upgrade
Research & Development	427.72	477.42	601.03	326.86	331.45	Upgrade
Operating Expenses	722.86	714.79	796.33	484.6	427.84	Upgrade
Operating Income	-486.28	-537.52	-641.98	308.71	-361.33	Upgrade
Interest Expense / Income	18.79	16.77	-2.39	-6.6	-13.73	Upgrade
Other Expense / Income	0.95	-2	1.49	0.37	0.1	Upgrade
Pretax Income	-506.02	-552.28	-641.08	314.94	-347.69	Upgrade
Income Tax	0.97	5.24	3	1.06	0	Upgrade
Net Income	-506.98	-557.52	-644.09	313.88	-347.69	Upgrade
Shares Outstanding (Basic)	61	60	59	55	48	Upgrade
Shares Outstanding (Diluted)	61	60	59	56	48	Upgrade
Shares Change	1.54%	1.92%	4.18%	17.44%	9.03%	Upgrade
EPS (Basic)	-8.37	-9.35	-11.01	5.76	-7.27	Upgrade
EPS (Diluted)	-8.37	-9.35	-11.01	5.59	-7.27	Upgrade
Free Cash Flow	-452.91	-511.2	-301.74	383.88	-292.03	Upgrade
Free Cash Flow Per Share	-7.48	-8.57	-5.16	7.04	-6.11	Upgrade
Gross Margin	94.87%	86.88%	85.71%	99.95%	100.00%	Upgrade
Operating Margin	-194.99%	-263.44%	-356.50%	38.89%	-543.25%	Upgrade
Profit Margin	-203.30%	-273.24%	-357.67%	39.54%	-522.75%	Upgrade
Free Cash Flow Margin	-181.61%	-250.54%	-167.56%	48.36%	-439.06%	Upgrade
Effective Tax Rate	-	-	-	0.34%	-	Upgrade
EBITDA	-466.45	-515.42	-630.69	320.69	-351.18	Upgrade
EBITDA Margin	-187.04%	-252.61%	-350.22%	40.40%	-527.99%	Upgrade
Depreciation & Amortization	20.77	20.1	12.79	12.35	10.25	Upgrade
EBIT	-487.22	-535.51	-643.47	308.34	-361.43	Upgrade
EBIT Margin	-195.37%	-262.46%	-357.32%	38.85%	-543.40%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).